Beth C Holbrook

Publication Activity (10 Years)

Years Active: 2022-2024
Publications (10 Years): 5

Top Topics

Community Dwelling

Low Birth Weight

Immune Response

Induced Pluripotent Stem Cells

Top Venues

Clinical cancer research : an official journal of the American Association for Cancer Research

This page only lists publications with an associated author ORCID identifier.

Publications

Beth C Holbrook, Elene A Clemens, Martha A Alexander-Miller
Sex-Dependent Effects on Influenza-Specific Antibody Quantity and Neutralizing Activity following Vaccination of Newborn Non-Human Primates Is Determined by Adjuvants. Vaccines 12 (4) (2024)
Beth C Holbrook, Elene A Clemens, Martha A Alexander-Miller
Sex-Dependent Effects on Influenza-Specific Antibody Quantity and Neutralizing Activity following Vaccination of Newborn Non-Human Primates Is Determined by Adjuvants. Vaccines 12 (4) (2024)
Kali F Crofts, Beth C Holbrook, Ralph B D'Agostino, Martha A Alexander-Miller
Analysis of R848 as an Adjuvant to Improve Inactivated Influenza Vaccine Immunogenicity in Elderly Nonhuman Primates. Vaccines 10 (4) (2022)
Pierre L Triozzi, Elizabeth R Stirling, Qianqian Song, Brian Westwood, Mitra Kooshki, M Elizabeth Forbes, Beth C Holbrook, Katherine L Cook, Martha A Alexander-Miller, Lance D Miller, Wei Zhang, David R Soto-Pantoja
Circulating Immune Bioenergetic, Metabolic, and Genetic Signatures Predict Melanoma Patients' Response to Anti-PD-1 Immune Checkpoint Blockade. Clinical cancer research : an official journal of the American Association for Cancer Research 28 (6) (2022)
Elene A Clemens, Beth C Holbrook, Brendan McNeilly, Masaru Kanekiyo, Barney S Graham, Martha A Alexander-Miller
TLR agonists induce sustained IgG to hemagglutinin stem and modulate T cells following newborn vaccination. NPJ vaccines 7 (1) (2022)